Dyadic International Inc (DYAI)

[tykundegex]

I'm not expecting this to be announced before the fourth quarter of 2019. If it comes sooner IMO it's a really great sign of how adaptable this platform really is and how adept the team is at engineering it.. which speaks volumes to its potential.

If they humanize C1 and demonstrate expressing nivolumab at higher rates and lower costs, then we'd have a true "back up the truck" situation on our hands.